A review of DTCA techniques: Appraising their success and potential impact on medication users

Fligstein, 2002, Agreements, disagreements, and opportunities in the ‘New sociology of Markets' Arney, 2014, Disease mongering in direct-to-consumer advertising and the expansion of the antidepressant market, Sociol Inq, 84, 519 Ventola, 2011, Direct-to-Consumer pharmaceutical advertising: therapeutic or toxic?, P T, 36, 669 Main, 2004, Pharmaceutical advertising in the USA: information or influence?, Int J Advert, 23, 119, 10.1080/02650487.2004.11072875 Rosenthal, 2003 Every-Palmer, 2014, Direct-to-consumer advertising of prescription medication in New Zealand, N. Z Med J, 127, 102 Hall, 2011, Direct to consumer advertising versus disease awareness advertising: consumer perspectives from down under, J Public Aff, 11, 60 Hoek, 2011, Information accessibility and consumers' knowledge of prescription drug benefits and risks, J Consum. Aff, 45, 248, 10.1111/j.1745-6606.2011.01202.x Ministry of Health, 2006 Sheehy, 2014, In New Zealand, finding a healthy balance, N. Z Med J, 127, 66 Mackey, 2015, It's time to shine the light on direct-to-consumer advertising, Ann Fam Med, 13, 82, 10.1370/afm.1711 Greene, 2010, Hidden in plain sight marketing prescription drugs to consumers in the twentieth century, Am J Public Health, 100, 793, 10.2105/AJPH.2009.181255 Macias, 2010, The changing face of direct-to-consumer print advertising, Pharm Med, 24, 165, 10.1007/BF03256813 Tyrawski, 2015, Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites, J Med Internet Res, 17, e130, 10.2196/jmir.4357 Conrad, 1992, Medicalization and social control, Annu Rev Sociol, 18, 209, 10.1146/annurev.so.18.080192.001233 O'Donoghue, 2014, Presenting efficacy information in direct-to-consumer prescription drug advertisements, Patient Educ Couns, 95, 271, 10.1016/j.pec.2013.12.010 Sullivan, 2016, Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: a randomized study, Patient Educ Couns, 99, 790, 10.1016/j.pec.2015.12.015 O'Donoghue, 2014, Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall, Soc Sci Med, 120, 1, 10.1016/j.socscimed.2014.08.039 Rollins, 2011, Nonbranded or branded direct-to-consumer prescription drug advertising-which is more effective?, Health Mark Q, 28, 86, 10.1080/07359683.2011.545337 Rollins, 2010, Behavioral intentions and information-seeking behavior: a comparison of nonbranded versus branded direct-to-consumer prescription advertisements, Drug Inf J, 44, 673, 10.1177/009286151004400603 Hall, 2011, Direct to consumer advertising versus disease awareness advertising: consumer perspectives from down under, J Public Aff, 11, 60 Khanfar, 2007, FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?, Health Mark Q, 24, 77, 10.1080/07359680802125899 Hoek, 2011, Information accessibility and consumers' knowledge of prescription drug benefits and risks, J Consum. Aff, 2011, 2 Kees, 2008, Barely or fairly balancing drug risks? Content and format effects in direct-to-consumer online prescription drug promotions, Psychol Mark, 25, 675, 10.1002/mar.20231 Tsai, 2012, Message strategies in direct-to-consumer pharmaceutical advertising: a content analysis using Taylor's six-segment message strategy wheel, Health Mark Q, 29, 239, 10.1080/07359683.2012.705708 Golan, 2008, Creative strategies in viral advertising: an application of Taylor's six-segment message strategy wheel, J Comput Mediat Commun, 13, 959, 10.1111/j.1083-6101.2008.00426.x Bhutada, 2012, Impact of celebrity pitch in direct-to-consumer advertising of prescription drugs, Health Mark Q, 29, 35, 10.1080/07359683.2012.652576 Bhutada, 2015, Disease-specific direct-to-consumer advertising of pharmaceuticals: an examination of endorser type and gender effects on consumers' attitudes and behaviors, Res Soc Adm Pharm, 11, 891, 10.1016/j.sapharm.2015.02.003 Liang, 2011, Prevalence and global health implications of social media in direct-to-consumer drug advertising, J Med Internet Res, 13, e64, 10.2196/jmir.1775 Tyrawski, 2015, Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites, J Med Internet Res, 17, e130, 10.2196/jmir.4357 Fogel, 2009, Direct-to-consumer advertisements of prescription medications over the Internet, Health Mark Q, 26, 347, 10.1080/07359680903304310 Huh, 2014, Trust in prescription drug brand websites: website trust cues, attitude toward the website, and behavioral intentions, J Health Commun, 19, 170, 10.1080/10810730.2013.798386 Gilbody, 2005, Benefits and harms of direct to consumer advertising: a systematic review, Qual Saf Health Care, 14, 246, 10.1136/qshc.2004.012781 Ebeling, 2011, 'Get with the Program!': pharmaceutical marketing, symptom checklists and self-diagnosis, Soc Sci Med, 73, 825, 10.1016/j.socscimed.2011.05.054 Aiken, 2004 Delbaere, 2006, Health care knowledge and consumer learning: the case of direct-to-consumer drug advertising, Health Mark Q, 23, 9, 10.1080/07359680802086059 Ang, 1994, Comparative advertising: superiority despite interference?, Asia Pac J Manag, 11, 33, 10.1007/BF01731871 Grewal, 1997, Comparative versus noncomparative advertising: a meta-analysis, J Mark, 61, 1 Liang, 2011, Direct-to-consumer advertising with interactive internet media: global regulation and public health issues, JAMA, 305, 824, 10.1001/jama.2011.203 Khanfar, 2008, FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?, Health Mark Q, 24, 77, 10.1080/07359680802125899